LUNG · Pulmonx Corp
United States · RS rating 98 · As of 2026-11-03
| Price | 2.72 USD |
|---|---|
| 1-day change | +5.4% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 98 / 94 / 79 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 43 / 55 / 56 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +26.5% |
| Sales growth Q/Q | +5.1% |
| Distance from 52-week high | +14.1% |
| Market cap (USD) | $54.1M |